Huagai Capital

Huagai Capital is a private equity investment firm established in 2012, specializing in investments within the healthcare and biotechnology sectors in China. The firm is dedicated to promoting the growth of Chinese small and medium-sized enterprises into industry leaders. Huagai Capital manages several equity investment funds, including medical health funds, TMT funds, and cultural funds, with assets under management exceeding 10 billion RMB.

The firm's investment strategy encompasses various stages, from early-stage ventures to pre-IPO and buyout opportunities. Huagai Capital's portfolio includes companies in healthcare, technology, business services, transport, financial services, and biotechnology. The firm is headquartered in Beijing, China, and primarily focuses its investments within the Chinese market.

Huagai Capital is co-founded by Xu Xiaolin and Lu Binghui, both of whom have extensive experience in domestic and international capital markets. Xu Xiaolin serves as the Chairman and co-founder, while Lu Binghui holds the position of President and co-founder. Their leadership and expertise have been instrumental in the firm's growth and success in the private equity sector.